[1]郭晓芳.小牛血去蛋白提取物眼用凝胶在角膜损伤修复中的临床效果及对干眼的影响[J].医学信息,2024,37(14):134-137.[doi:10.3969/j.issn.1006-1959.2024.14.027]
　GUO Xiao-fang.Clinical Effect of Deproteinized Calfblood Extract Eye Gel in Corneal Injury Repair and its Effect on Dry Eye[J].Journal of Medical Information,2024,37(14):134-137.[doi:10.3969/j.issn.1006-1959.2024.14.027]
点击复制

小牛血去蛋白提取物眼用凝胶在角膜损伤修复中的临床效果及对干眼的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年14期
页码:
134-137
栏目:
论著
出版日期:
2024-07-15

文章信息/Info

Title:
Clinical Effect of Deproteinized Calfblood Extract Eye Gel in Corneal Injury Repair and its Effect on Dry Eye
文章编号:
1006-1959（2024）14-0134-04
作者:
郭晓芳
（安福县人民医院五官科，江西 安福 343200）
Author(s):
GUO Xiao-fang
(Department of Ophthalmology and Otorhinolaryngology,Anfu County People’s Hospital,Anfu 343200,Jiangxi,China)
关键词:
小牛血去蛋白提取物眼用凝胶; 角膜损伤; 干眼
Keywords:
Deproteinized calfblood extract eye gel; Corneal injury; Dry eye
分类号:
R772.2
DOI:
10.3969/j.issn.1006-1959.2024.14.027
文献标志码:
A
摘要:
目的 观察小牛血去蛋白提取物眼用凝胶在角膜损伤修复中的临床效果及对干眼的影响。方法 选取2021年1月-2023年6月我院诊治的68例角膜损伤患者为研究对象，采用随机数字表法分为对照组和观察组，各组34例。对照组采用重组牛碱性成纤维细胞生长因子眼用凝胶治疗，观察组采用小牛血去蛋白提取物眼用凝胶治疗，比较两组临床治疗效果、角膜上皮修复时间、干眼症状评分、角膜表层上皮细胞密度和面积、眼部功能指标[角膜荧光染色评分（CFS）、泪膜破裂时间（BUT）]及临床不良反应发生情况。结果 观察组治疗总有效率为94.12%，高于对照组的82.35%（P＜0.05）；观察组角膜上皮修复时间短于对照组，干眼症状评分低于对照组（P＜0.05）；两组治疗后角膜表层上皮细胞密度大于治疗前，角膜表层上皮细胞面积小于治疗前，且观察组角膜表层上皮细胞密度大于对照组，角膜表层上皮细胞面积小于对照组（P＜0.05）；两组治疗后CFS评分低于治疗前，BUT大于治疗前，且观察组CFS评分低于对照组，BUT大于对照组（P＜0.05）；观察组不良反应发生率为8.82%，与对照组的11.76%比较，差异无统计学意义（P＞0.05）。结论 小牛血去蛋白提取物眼用凝胶可提高角膜损伤修复效果，缩短修复时间，减轻干眼症状，改善眼部功能指标，增大角膜表层上皮细胞密度，减小角膜表层上皮细胞面积，且不良反应轻微。
Abstract:
Objective To observe the effect of deproteinized calfblood extract eye gel in corneal injury repair and its effect on dry eye.Methods A total of 68 patients with corneal injury diagnosed and treated in our hospital from January 2021 to June 2023 were selected as the research objects. They were divided into control group and observation group by random number table method, with 34 patients in each group. The control group was treated with recombinant bovine basic fibroblast growth factor ophthalmic gel, and the observation group was treated with deproteinized calfblood extract eye gel. The clinical treatment effect, corneal epithelial repair time, dry eye symptom score, corneal epithelial cell density and area, eye function index [corneal fluorescence staining score (CFS), tear film rupture time (BUT)] and clinical adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 94.12%, which was higher than 82.35% in the control group (P<0.05). The corneal epithelial repair time in the observation group was shorter than that in the control group, and the dry eye symptom score was lower than that in the control group (P<0.05). After treatment, the density of corneal epithelial cells in the two groups was higher than that before treatment, and the area of corneal epithelial cells was smaller than that before treatment， while the density of corneal epithelial cells in the observation group was higher than that in the control group, and the area of corneal epithelial cells was smaller than that in the control group (P<0.05). After treatment, the CFS score of the two groups was lower than that before treatment, and the BUT was higher than that before treatment, while the CFS score of the observation group was lower than that of the control group, and the BUT was higher than that of the control group (P<0.05). The incidence of adverse reactions in the observation group was 8.82%, which was compared with 11.76% in the control group, the difference was not statistically significant (P>0.05).Conclusion Deproteinized calfblood extract eye gel can improve the repair effect of corneal injury, shorten the repair time, reduce the symptoms of dry eye, improve the ocular function index, increase the density of corneal surface epithelial cells, and reduce the area of corneal surface epithelial cells, with mild adverse reactions.

参考文献/References:

[1]郑霄,刘莛,陈侠,等.小牛血去蛋白提取物滴眼液治疗白内障术后角膜上皮功能障碍的临床疗效观察[J].重庆医学,2020,49(18):2975-2978,2983.[2]陈鑫,沈烨宇.重组牛碱性成纤维细胞生长因子联合玻璃酸钠治疗超声乳化术后干眼[J].国际眼科杂志,2019,19(2):280-284. [3]Miyazaki D,Fukushima A,Ohashi Y,et al.Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular Diseases[J].Ophthalmology,2017,124(3):287-294.[4]刘梅香,韩曙生.角膜塑形镜联合小牛血去蛋白提取物滴眼液矫正青少年近视的效果研究[J].检验医学与临床,2020,17(19):2814-2817.[5]钱丽洁,黄艳丽,王雄.重组牛碱性成纤维细胞生长因子对光损伤HaCaT细胞修复作用[J].中国中西医结合皮肤性病学杂志,2019,18(3):231-233.[6]梁璐琦.重组牛碱性成纤维细胞生长因子滴眼液分别联合普拉洛芬和妥布霉素地塞米松滴眼液治疗白内障术后角膜水肿的临床效果[J].山西医药杂志,2021,50(1):67-70.[7]高路,陈坤福,姜成,等.滋阴明目汤口服联合玻璃酸钠滴眼液治疗准分子激光角膜原位磨镶术后并发干眼的临床观察[J].四川中医,2022,40(11):194-197.[8]王爽,苏冉,张前辉.重组牛碱性成纤维细胞生长因子治疗外伤性角膜上皮缺损的临床疗效观察[J].四川解剖学杂志,2020,28(3):177-178.[9]Chen W,Guo J,Guo H,et al.Protective Effect of Vitamin C against Infancy Rat Corneal Injury Caused by Acute UVB Irradiation[J].Biomed Res Int,2020,2020:8089273.[10]吴慧敏,赛那,杜雪莹,等.珍珠明目滴眼液改善TNF-α和IFN-γ诱导人角膜上皮细胞损伤的作用[J].中华中医药杂志,2022,37(4):2311-2315.[11]王丽.生长因子修饰PGCL仿生组织工程角膜的制备及其对角膜损伤修复的研究[D].长春:吉林大学,2022.[12]金潇,秦应祥,胥陶,等.玻璃酸钠滴眼液联合重组人表皮生长因子滴眼液改善老年白内障患者术后角膜损伤和修复角膜内皮细胞的研究[J].老年医学与保健,2020,26(4):579-582.[13]张弛,赵刚平,王萍,等.重组人生长激素对兔角膜损伤早期修复的研究[J].国际眼科杂志,2021,21(6):975-979.[14]李严为.除风益损汤联合小牛血眼用凝胶对眼化学性伤后角膜损伤恢复的临床疗效观察[D].南昌:江西中医药大学,2022. [15]曹妍.特异结合重组碱性成纤维细胞生长因子对角膜上皮损伤愈合的影响[D].长春:吉林大学,2019.[16]王亚灵,董诺,林志荣,等.角膜绷带镜联合人工泪液治疗霰粒肿刮除术后角膜上皮损伤的疗效观察[J].中国卫生标准管理,2018,9(7):51-53.[17]Kaido M,Inoue S,Kawashima M,et al.Capsaicin-induced pain sensitivity in short tear break-up time dry eye[J].Ocul Surf,2020,18(4):620-626.[18]王小东,李宏松,程钰,等.三种角膜修复剂促角膜损伤修复的临床效果观察[J].陕西医学杂志,2017,46(2):218-220.[19]潘华婴,赵成海,魏文斌.不同胎牛血清浓度培养的人脐带间充质干细胞的条件培养基对角膜上皮细胞损伤修复的影响[J].中国药物与临床,2021,21(6):917-920.[20]吴漾.干眼对角膜上皮细胞能量代谢的影响及补充氨基酸对干眼的治疗作用[D].厦门:厦门大学,2019.

更新日期/Last Update: 1900-01-01